ABCL - AbCellera Biologics Inc.
2.03
-0.160 -7.882%
Share volume: 5,098,071
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$2.19
-0.16
-0.07%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-07-2024 | 08-03-2023 | 11-02-2023 | 11-04-2024 | 05-07-2024 | 08-06-2024 | 11-04-2024 | 02-27-2025 | |
Total revenue | 12.192 M | 10.056 M | 6.599 M | 9.178 M | 9.954 M | 7.323 M | 6.507 M | 5.049 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 12.192 M | 10.056 M | 6.599 M | 9.178 M | 9.954 M | 7.323 M | 6.507 M | 5.049 M | |
-17.52% | -34.38% | 39.08% | 8.46% | -26.43% | -11.14% | -22.41% | |||
Operating expenses | 67.781 M | 51.994 M | 52.286 M | 64.596 M | 56.639 M | 61.119 M | 60.116 M | 62.096 M | |
Selling general and admin | 15.134 M | 15.521 M | 14.369 M | 15.975 M | 17.352 M | 20.192 M | 19.147 M | 16.020 M | |
Research and development | 52.647 M | 36.473 M | 37.917 M | 48.621 M | 39.287 M | 40.927 M | 40.969 M | 46.076 M | |
Total expenses | 77.066 M | 61.445 M | 61.489 M | 75.232 M | 64.848 M | 100.777 M | 100.170 M | 77.804 M | |
-20.27% | 0.07% | 22.35% | -13.80% | 55.40% | -0.60% | -22.33% | |||
Operating income | -64.874 M | -51.389 M | -54.890 M | -66.054 M | -54.894 M | -93.454 M | -93.663 M | -72.755 M | |
Ebit | -57.907 M | -48.783 M | -50.016 M | -59.570 M | -53.148 M | -57.988 M | -72.235 M | -55.497 M | |
Pretax income | -48.148 M | -38.004 M | -39.276 M | -48.601 M | -42.747 M | -48.187 M | -62.632 M | -46.829 M | |
-21.07% | 3.35% | 23.74% | -12.05% | 12.73% | 29.98% | -25.23% | |||
Income tax | -8.038 M | -7.476 M | -10.666 M | -1.451 M | -2.137 M | -11.257 M | -11.525 M | -12.619 M | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -40.110 M | -30.528 M | -28.610 M | -47.150 M | -40.610 M | -36.930 M | -51.107 M | -34.210 M | |
23.89% | 6.28% | -64.80% | 13.87% | 9.06% | -38.39% | 33.06% |